SCHEMBL1710644

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL30029020	0.86	MTNR1A (0.47)	NPC1EPHX1MTNR1AMTNR1BACACB
	SCHEMBL13400276	0.82	EPHX1 (0.41)	CA1CA2RAB9ASMN1; SMN2CTSK
	SCHEMBL13459733	0.81	GLS (0.44)	CA12CA1NPC1RAB9AEPHX1
	SCHEMBL1710349	0.81	EPHX1 (0.39)	CA1CA2SMN1; SMN2CTSKEPHX1
	SCHEMBL1710614	0.80	EPHX1 (0.39)	CA1CA2RAB9ASMN1; SMN2CTSK
	SCHEMBL3386798	0.80	EPHX1 (0.39)	CA1CA2CTSKEPHX1ACACB
	SCHEMBL1725728	0.80	EPHX1 (0.39)	CTSKEPHX1MEN1KMT2A
	SCHEMBL1710407	0.79	EPHX1 (0.38)	CTSKEPHX1IDO1
	SCHEMBL1725856	0.79	CA1 (0.51)	CA12CA1CA2CA9PDK2
	SCHEMBL3388602	0.79	EPHX1 (0.38)	CTSKEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.